文献速递外周动脉疾病

双导丝球囊导管对周围动脉慢性完全闭塞的内膜下穿越:PRAESTO研究

Subintimal Crossing of Chronic Total Occlusions in Peripheral Arteries With a Dual Guidewire Balloon Catheter: The PRAESTO Study.
PubMed 文献 · J Endovasc Ther · 2022-07-02

回顾性评分匹配分析比较双导丝球囊行顺行开窗再入(AFR)内膜下再通与常规内膜下再通治疗周围动脉疾病慢性完全闭塞。研究组30例、匹配对照组60例,研究组内膜下再入成功率100% vs 76.7%(p=0.004),远端胫动脉穿刺0 vs 14例(23.3%,p=0.004),手术时间、透视时间及剂量面积乘积均更低,一期通畅率、死亡率、截肢及免于再干预无显著差异。

要点

  • 研究组内膜下再入成功率100% vs 对照组76.7%(p=0.004)。
  • 研究组远端胫动脉穿刺0例 vs 对照组14例(23.3%,p=0.004)。
  • 一期通畅率、死亡率、截肢及免于再干预无显著差异。

核心结论

  • 作者认为,使用Presto双导丝球囊行AFR是穿越慢性完全闭塞的进步,相比常规方法可简化并快速治疗膝下和膝上病变,不增加手术风险且维持良好临床结局。

研究设计与样本

  • 回顾性评分匹配分析,研究组为接受双导丝球囊AFR内膜下再通治疗的周围动脉疾病慢性完全闭塞患者30例,匹配对照组为接受常规内膜下再通治疗的患者60例,按基线心血管危险因素和病变特征匹配。

主要发现

  • 研究组内膜下再入成功率100% vs 对照组76.7%(p=0.004)。
  • 研究组远端胫动脉穿刺0例 vs 对照组14例(23.3%,p=0.004)。
  • 对照组5例需转为外科旁路手术。
  • 研究组剂量面积乘积914.1±309.9 µGym² vs 对照组2026.5±845.7 µGym²(p<0.001)。

关键数值与推荐

  • 研究组内膜下再入成功率100% vs 对照组76.7%(p=0.004)。
  • 研究组远端胫动脉穿刺0例 vs 对照组14例(23.3%,p=0.004)。
  • 研究组透视时间16.7±3.5分钟 vs 对照组34.3±14.2分钟(p<0.001)。
  • 研究组剂量面积乘积914.1±309.9 µGym² vs 对照组2026.5±845.7 µGym²(p<0.001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The purpose of this study was to evaluate the safety and efficacy of antegrade fenestration re-entry (AFR) using a dual guidewire angioplasty balloon for chronic total occlusion (CTO) in patients with peripheral artery disease (PAD). MATERIAL AND METHODS: This is a retrospective score matching analysis study comparing a study cohort composed of PAD patients with CTO treated with AFR subintimal recanalization using a dual guidewire angioplasty balloon and a matched control group, selected on baseline cardiovascular risk factor and lesions characteristics, treated with a conventional subintimal recanalization. Procedure outcomes include procedural success, successful subintimal re-entry, need for distal puncture, procedural time, fluoroscopy time, and dose area product. Clinical variables, including primary patency, freedom from amputation, freedom from re-interventions, and freedom from death, were used to compare the study groups. RESULTS: Thirty patients in the study group were compared with 60 patients in the matched control group (mean age, male). A significant higher subintimal re-entry success (100% vs 76.7% in control group, p=0.004) and lower need of distal tibial punction (0 vs 14 [23.3%] patients in control group, p=0.004) were observed in the study group. A surgical conversion to bypass was needed in 5 patients in the control group. Shorter procedural and fluoroscopy time were observed in the study group (41.1±10.8 minutes vs 146.6±62. and 16.7±3.5 minutes vs 34.3±14.2 minutes in control group respectively, p<0.001 and p<0.001). Lower DAP were observed in the study group (914.1±309.9 µGym² vs 2026.5±845.7 µGym² in control group p<0.001). No significant difference were observed in terms of primary patency, mortality, amputation, and freedom from re-intervention. CONCLUSION: AFR using the Presto dual guidewire balloon is a step forward for crossing CTO which allows a simplified and quick treatment of BTK and ATK lesions compared with conventional approaches without increase of procedural risk and maintaining good clinical outcomes.

来源:J Endovasc Ther,查看原文。版权归原作者所有。

引用

  1. Del Giudice C, Gandini R. Subintimal Crossing of Chronic Total Occlusions in Peripheral Arteries With a Dual Guidewire Balloon Catheter: The PRAESTO Study. J Endovasc Ther. 2022. PMID: 35786089. doi:10.1177/15266028221106308

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。